Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3123 | 1978 | 51.2 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OREXIN | Author keyword | 667 | 65% | 32% | 638 |
2 | OREXIN A | Author keyword | 371 | 83% | 11% | 208 |
3 | HYPOCRETIN | Author keyword | 362 | 63% | 19% | 367 |
4 | SB 334867 | Author keyword | 136 | 94% | 2% | 48 |
5 | OREXIN RECEPTORS | Author keyword | 89 | 90% | 2% | 38 |
6 | OREXIN 1 RECEPTOR | Author keyword | 87 | 94% | 2% | 31 |
7 | OREXINS | Author keyword | 71 | 62% | 4% | 73 |
8 | OREXIN B | Author keyword | 67 | 89% | 2% | 31 |
9 | ALMOREXANT | Author keyword | 56 | 89% | 1% | 25 |
10 | MOL NEUROSCI INTEGRAT PHYSIOL | Address | 51 | 70% | 2% | 42 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OREXIN | 667 | 65% | 32% | 638 | Search OREXIN | Search OREXIN |
2 | OREXIN A | 371 | 83% | 11% | 208 | Search OREXIN+A | Search OREXIN+A |
3 | HYPOCRETIN | 362 | 63% | 19% | 367 | Search HYPOCRETIN | Search HYPOCRETIN |
4 | SB 334867 | 136 | 94% | 2% | 48 | Search SB+334867 | Search SB+334867 |
5 | OREXIN RECEPTORS | 89 | 90% | 2% | 38 | Search OREXIN+RECEPTORS | Search OREXIN+RECEPTORS |
6 | OREXIN 1 RECEPTOR | 87 | 94% | 2% | 31 | Search OREXIN+1+RECEPTOR | Search OREXIN+1+RECEPTOR |
7 | OREXINS | 71 | 62% | 4% | 73 | Search OREXINS | Search OREXINS |
8 | OREXIN B | 67 | 89% | 2% | 31 | Search OREXIN+B | Search OREXIN+B |
9 | ALMOREXANT | 56 | 89% | 1% | 25 | Search ALMOREXANT | Search ALMOREXANT |
10 | OREXIN RECEPTOR | 50 | 81% | 2% | 30 | Search OREXIN+RECEPTOR | Search OREXIN+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPOCRETIN OREXIN | 413 | 67% | 19% | 375 |
2 | HUMAN NARCOLEPSY | 202 | 72% | 8% | 157 |
3 | PREPRO OREXIN | 166 | 88% | 4% | 79 |
4 | HYPOTHALAMIC NEUROPEPTIDES | 154 | 76% | 5% | 108 |
5 | OREXIN HYPOCRETIN | 131 | 81% | 4% | 78 |
6 | HYPOCRETINS | 100 | 77% | 3% | 69 |
7 | OREXIN HYPOCRETIN NEURONS | 100 | 81% | 3% | 60 |
8 | HYPOCRETIN | 85 | 60% | 5% | 93 |
9 | NARCOLEPSY | 83 | 26% | 14% | 273 |
10 | OREXIN A | 66 | 46% | 5% | 107 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The hypocretins/orexins: integrators of multiple physiological functions | 2014 | 23 | 297 | 88% |
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness | 2007 | 405 | 100 | 74% |
Discovery and development of orexin receptor antagonists as therapeutics for insomnia | 2014 | 22 | 57 | 81% |
Orexin/hypocretin role in reward: implications for opioid and other addictions | 2015 | 5 | 146 | 58% |
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System | 2009 | 163 | 132 | 80% |
Orexin Receptors: Pharmacology and Therapeutic Opportunities | 2011 | 90 | 131 | 79% |
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012 | 2013 | 31 | 402 | 77% |
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls | 2014 | 11 | 124 | 87% |
The role of orexin in motivated behaviours | 2014 | 11 | 144 | 87% |
Role of orexin in modulating arousal, feeding, and motivation | 2013 | 26 | 156 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL NEUROSCI INTEGRAT PHYSIOL | 51 | 70% | 2.1% | 42 |
2 | NARCOLEPSY | 12 | 25% | 2.1% | 41 |
3 | ERATO YANAGISAWA ORPHAN RECEPTOR PROJECT | 6 | 58% | 0.4% | 7 |
4 | SLEEP 151A3 | 4 | 75% | 0.2% | 3 |
5 | DEP S CIRCADIAN DISORDERS | 4 | 44% | 0.4% | 7 |
6 | YANAGISAWA ORPHAN RECEPTOR PROJECT | 4 | 31% | 0.5% | 10 |
7 | STANFORD NARCOLEPSY | 3 | 50% | 0.3% | 5 |
8 | EXPLORATORY ADV TECHNOL YANAGISAWA ORPHAN REC | 3 | 57% | 0.2% | 4 |
9 | EXPLORATORY ADV TECHNOL YANAGISAWA ORPHAN PRO | 3 | 100% | 0.2% | 3 |
10 | DIPARTIMENTO SCI BIOPATOL VET IGIENE PROD ANIM | 3 | 42% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000214901 | NARCOLEPSY//CATAPLEXY//IDIOPATHIC HYPERSOMNIA |
2 | 0.0000139553 | MELANIN CONCENTRATING HORMONE//MELANIN CONCENTRATING HORMONE MCH//MCH |
3 | 0.0000088750 | SLEEP HOMEOSTASIS//EEG DELTA POWER//VENTROLATERAL PREOPTIC AREA |
4 | 0.0000075128 | NEUROPEPTIDE S//NEUROPEPTIDE S RECEPTOR//NPSR |
5 | 0.0000067681 | PEDUNCULOPONTINE NUCLEUS//PEDUNCULOPONTINE TEGMENTAL NUCLEUS//POSTURAL MUSCLE TONE |
6 | 0.0000065752 | CART PEPTIDE//COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT//CART |
7 | 0.0000057601 | HYPOTHALAM//A2 NORADRENERGIC NEURONS//LASER CATAPULT MICRODISSECTION |
8 | 0.0000049674 | NEUROMEDIN U//NEUROPEPTIDE W//NEUROMEDIN S |
9 | 0.0000045145 | SOCIAL SEPARATION STRESS//ADV ANIM MARINE BIO OURCES//REGULAT METAB BEHAV |
10 | 0.0000036699 | BED NUCLEUS OF THE STRIA TERMINALIS//EXTENDED AMYGDALA//CORTICAL AUTONOMIC NETWORK |